Medical Properties Trust (MPT) Q4 2024 earnings summary

Executive summary

• Executed $5.5 billion in asset monetization, including a $2.5 billion senior secured notes offering at a 7.88% blended coupon, addressing all debt maturities through 2026.

• Achieved a global settlement with Prospect Medical Holdings, facilitating asset sales and providing $25 million in funding to support the bankruptcy process, with proceeds primarily allocated to creditors, pending court approval.

• Portfolio diversification improved with new operators, and hospital fundamentals strengthened, evidenced by growing admissions, surgical volumes, and improved coverage ratios both sequentially and year-over-year.

• Most new operators are now cash flow positive, and contractual cash rent from new leases is ramping up, expected to reach $40 million per quarter by October 2026.

• Portfolio consists of 396 properties and 39,000 licensed beds across nine countries, with total assets of $14.3 billion as of December 31, 2024.

Financial highlights

• Reported a GAAP net loss of $413 million and normalized FFO of $0.18 per share for Q4 2024; full-year GAAP net loss was $2.4 billion ($4.02 per share) with normalized FFO of $0.80 per share.

• Q4 results were impacted by $415 million in impairments and adjustments related to Prospect's bankruptcy, representing about one-third of the previous investment.

• Revenues for 2024 were $995.5 million, compared to $871.8 million in 2023.

• Dividends declared per share: $0.08 for Q4 2024, $0.46 for full-year 2024, compared to $0.15 and $0.88, respectively, in 2023.

• Received a $10 million rent catch-up payment from a small tenant, included in normalized FFO.

Outlook and guidance

• Expect annualized cash rent of over $1 billion once new tenants are fully ramped.

• Liquidity sufficient to cover debt obligations through October 2027, with flexibility for further asset sales, joint ventures, and portfolio repositioning.

• Anticipate incremental $0.06 per share in quarterly FFO from new lease rent ramp-up by October 2026.

• Positioned to pursue a range of shareholder value initiatives in 2025 after addressing all debt maturities through 2026.

• Settlement with Prospect Medical Group to enable sale of hospitals and related real estate, subject to bankruptcy court approval.